Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches
Elad Mashiach(New York University), Douglas Kondziolka(Neurological Surgery), Fernando De Nigris Vasconcellos(Boston Medical Center), John G. Golfinos(NYU Langone Health), Zane Schnurman(Neurological Surgery), Rishitha Bollam(NYU Langone Health), Sylvia Adams(NYU Langone Health), Cordelia Orillac(Neurological Surgery), Kenneth Bernstein(NYU Langone Health), Maryann Kwa(NYU Langone Health), Ruth Oratz(NYU Langone Health), Joshua S. Silverman(NYU Langone Health), Yelena Novik(NYU Langone Health), Brandon Santhumayor(North Shore Diabetes and Endocrine Associates), Ying Meng(Sunnybrook Health Science Centre), Bernadine R. Donahue(Maimonides Medical Center), David H. Harter(NYU Langone Health), Marleen Meyers(NYU Langone Health), Juan Diego Alzate(Neurological Surgery)
Cited by 5
Related Papers
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
|Journal of Clinical Oncology|2014|1.3k
The Intestinal Microbiome and Estrogen Receptor–Positive Female Breast Cancer
|JNCI Journal of the National Cancer Institute|2016|521
The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
|Journal of Neuro-Oncology|2009|514
Current Landscape of Immunotherapy in Breast Cancer
|JAMA Oncology|2019|409